Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 2 (T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07289750
What this trial is testing

The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD

Who this might be right for
T2DMMAFLD
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 80
Not applicableStudy completedNCT06111508
What this trial is testing

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Who this might be right for
Type 2 Diabetes
University of Virginia 30
Large-scale testing (Phase 3)Ended earlyNCT03608358
What this trial is testing

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 41
Not applicableNot Yet RecruitingNCT07124585
What this trial is testing

Short-Term Effects of Sucralose and Saccharin on Blood Sugar and Gut Microbiota in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
National University of Malaysia 33
Post-approval studies (Phase 4)Study completedNCT01107717
What this trial is testing

Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

Who this might be right for
Diabetes
The University of Texas Health Science Center at San Antonio 318
Not applicableNot Yet RecruitingNCT07708610
What this trial is testing

Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes

Who this might be right for
PneumoniaType 2 Diabetes Mellitus (T2DM)
Chung Shan Medical University 71,775
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Post-approval studies (Phase 4)Active Not RecruitingNCT07325435
What this trial is testing

Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

Who this might be right for
Type 2 Diabetes (T2DM)
MaryAnn Banerji 60
Not applicableActive Not RecruitingNCT07045662
What this trial is testing

Health Literacy in Patients With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Ernanda Mezaroba 88
Not applicableStudy completedNCT06313008
What this trial is testing

Empagliflozin Versus Vildagliptin in CAD Patients With T2DM

Who this might be right for
Coronary Artery DiseaseType 2 Diabetes
Damanhour University 120
Not applicableLooking for participantsNCT07690163
What this trial is testing

DIabetes GLycemic Assessment in Newly Confirmed Episodes

Who this might be right for
Type 2 Diabetes (T2DM)Obesity Type 2 Diabetes MellitusObesity & Overweight+1 more
Nazarii Kobyliak 80
Post-approval studies (Phase 4)Study completedNCT03120299
What this trial is testing

The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)

Who this might be right for
Type 2 Diabetes MellitusHypertriglyceridemia
Shanghai Jiao Tong University School of Medicine 309
Large-scale testing (Phase 3)Study completedNCT01733758
What this trial is testing

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 494
Not applicableUnknownNCT03257449
What this trial is testing

Effect of Viscous Soluble Fibres on Body Weight

Who this might be right for
Overweight and ObesityT2DM (Type 2 Diabetes Mellitus)General Population
Unity Health Toronto 1,268
Not applicableStudy completedNCT02798198
What this trial is testing

The Correlation Between the Pulmonary Function and Intrarenal Hemodynamics in 37 T2DM Patients in Early Period

Who this might be right for
Diabetes Mellitus, Type 2
Fourth People's Hospital of Shenyang 70
Large-scale testing (Phase 3)Looking for participantsNCT07093476
What this trial is testing

Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

Who this might be right for
T2DMDiabete Type 2DM
Celltrion 171
Testing effectiveness (Phase 2)Study completedNCT01677299
What this trial is testing

Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Elcelyx Therapeutics, Inc. 24
Not applicableEnrolling By InvitationNCT07387393
What this trial is testing

To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years

Who this might be right for
Cardiometabolic ConditionsHypertension (HTN)Dyslipidemia+4 more
University of Hawaii 400
Post-approval studies (Phase 4)Study completedNCT02380521
What this trial is testing

Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
University of Palermo 60
Not applicableLooking for participantsNCT06256419
What this trial is testing

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

Who this might be right for
Type 2 Diabetes MellitusSusceptibility, Genetic
The Affiliated Hospital of Xuzhou Medical University 300
Next Page